Molecular typing of the actinomycete Rhodococcus equi is insufficiently developed, and little is known about the epidemiology and transmission of this multihost pathogen. We report a simple, reliable polymerase chain reaction typing system for R. equi based on 3 plasmid gene markers: traA from the conserved conjugal transfer machinery and vapA and vapB, found in 2 different plasmid subpopulations. This "TRAVAP" typing scheme classifies R. equi into 4 categories: 
Molecular typing of the actinomycete Rhodococcus equi is insufficiently developed, and little is known about the epidemiology and transmission of this multihost pathogen. We report a simple, reliable polymerase chain reaction typing system for R. equi based on 3 plasmid gene markers: traA from the conserved conjugal transfer machinery and vapA and vapB, found in 2 different plasmid subpopulations. This "TRAVAP" typing scheme classifies R. 
/vapAB
Ϫ -a new type of R. equi plasmid-and cattle. Plasmidless strains were more frequent among isolates from nonpathological specimens. All plasmid categories were common in human isolates, which possibly reflects the predominantly opportunistic nature of R. equi infection in this host and a zoonotic origin.
The soilborne actinomycete Rhodococcus equi is an opportunistic pathogen capable of infecting a wide range of animal hosts, including humans. R. equi pulmonary and bacteremic infections occur primarily in immunocompromised patients, particularly in patients with AIDS and organ transplant recipients [1] [2] [3] [4] [5] . In the veterinary field, this organism is typically isolated from young foals with suppurative bronchopneumonia or mesenteric lymphadenitis, but it is increasingly being identified as the causative agent of pulmonary and extrapulmonary infections in other animal species [6] [7] [8] [9] [10] [11] [12] .
R. equi is ubiquitously distributed in the environment worldwide [13, 14] .
The virulence of R. equi is associated with the presence of large plasmids. In horse isolates, these plasmids are 85-90 kb in size and encode virulence-associated protein A (VapA), a 15-17-kDa surface lipoprotein antigen important for intramacrophage survival, cytotoxicity, and horse pathogenicity via unknown mechanisms [6, [13] [14] [15] [16] [17] . Most equine isolates are VapA + (or vapA + ), whereas strains with this marker are much less frequent among isolates from humans and other animal species [18] . In nonhorse hosts, a variant plasmid encoding VapB, a VapA-related surface antigen of larger size (18) (19) (20) , has been identified [19] [20] [21] . Lack of detection of VapA/B proteins (or vapA/B DNA sequences) is relatively common in nonhorse isolates [22] and is assumed to be due to an absence of virulence plasmids. However, these strains may carry other types of uncharacterized R. equi virulence-associated extrachromosomal replicons.
Although it is easy to distinguish between VapA and VapB plasmid types by current polymerase chain reaction (PCR)-based methods, the unambiguous dis- [2, 10, 11, 15] using methods that are cumbersome, time-consuming, and in some cases unreliable unless very carefully standardized and optimized. Indeed, the extraction of virulence-associated plasmids from R. equi is difficult and practiced by only a few laboratories worldwide. We report here a new "universal" plasmid marker for R. equi that facilitates the rapid discrimination between plasmid-positive and plasmid-negative strains by PCR. This PCR-based method targets the traA gene encoding a protein of the conserved conjugal transfer machinery of Rhodococcus species plasmids [23] [24] [25] . We incorporated this marker into a novel multiplex PCR assay with new vapA and vapB target sequences, making it possible to classify R. equi isolates into 4 major plasmid categories of epidemiological significance. [26] , and R. equi-specific choE PCR [27] . The bacteria were grown for 24-48 h at 30ЊC using brain-heart infusion (BHI) broth (Difco-BD) as the base medium, supplemented with 1.5% agar for plate cultures. Chemicals were purchased from Sigma-Aldrich unless otherwise stated.
MATERIALS AND METHODS

Bacterial
General DNA procedures and reagents. An R. equi genomic DNA template was prepared by suspending 1 colony in 50 mL of Instagene matrix (Bio-Rad) and heating for 20 min at 60ЊC. The samples were centrifuged at 10,000 g for 5 min, and the supernatants were used for PCR amplification. Highly purified, concentrated genomic DNA for use as a reference material was obtained as described elsewhere [18] . DNA was subjected to electrophoresis in 0.8% agarose gels at a constant voltage of 100 V for 30-60 min in 1ϫ TBE buffer (45 mmol/ L Tris-HCl, 45 mmol/L boric acid, and 1 mmol/L EDTA [pH 8]) and visualized under UV light after staining in 0.5 mg/mL ethidium bromide in TBE. DNA quality and concentration were assessed visually on gels and spectrophotometrically, by calculating the ratio of absorbance at 260 nm to that at 280 nm.
Plasmid DNA from R. equi strains was digested overnight with EcoRI endonuclease (New England Biolabs). Restriction fragments were resolved by electrophoresis in 1% agarose gels for 16 h at 40 V and were then transferred onto positively charged nylon membranes (Roche Diagnostics) by capillary action [28] . For Southern blotting, the traA probe was labeled and detected on blots by a luminescence-based method using the DIG-High Prime Labeling and Detection Kit (Roche Diagnostics) in accordance with the manufacturer's instructions. PCR products were purified using the QIAquick purification kit (Qiagen). DNA was sequenced on both strands at AGOWA (Berlin). Sequences were assembled with Vector NTI (version 9.0.0; InforMax software; Invitrogen) and analyzed with BLAST software [29] .
R. equi plasmid minipreparation. Plasmid DNA was isolated from early stationary-phase broth cultures of R. equi using the alkaline lysis method [13] , as follows. Bacteria were grown with vigorous rotary shaking (250 rpm) in horizontally set 15-mL screw-cap tubes that contained 10 mL of BHI broth; they were harvested by centrifugation at 11,000 g for 10 min at 4ЊC, washed with 1ϫ TBE (pH 7.5), transferred to 2-mL plastic microtubes, and centrifuged again under the same conditions. The bacterial pellets were resuspended in 0.2 mL of SETL solution (15% sucrose, 10 mmol/L EDTA, 25 mmol/L Tris-HCl [pH 8], and 5 mg/mL lysozyme) and incubated for 2-4 h at 37ЊC with shaking at 100 rpm, after which 0.4 mL of lysis solution (0.2 mol/L NaOH and 1% SDS) was added. The microtubes were inverted 250 times until a homogeneous viscous suspension was obtained; then, 0.3 mL of prechilled potassium acetate (5 mol/L) was added, and microtubes were inverted again 100 times and left on ice for 30 min. The mixtures were then centrifuged at 17,000 g for 10 min at 4ЊC, the supernatants were transferred to fresh 2-mL microtubes, and 10 mL of a 10 mg/mL solution of DNAse-free RNAse (Qiagen) was added. After incubation for 30 min at 37ЊC, the lysates were extracted with 0.5 mL of phenol-chloroform-isoamyl alcohol (25:24:1) by gently inverting 100 times and were then centrifuged for 10 min at 17,000 g and 4ЊC. The upper phase was carefully transferred to a fresh tube, and the plasmid DNA was precipitated by the addition of 0.5 mL of isopropanol. The precipitates were pelleted by centrifugation under the same conditions, the supernatant was carefully decanted, and the plasmid DNA was washed twice with 1 mL of 70% ethanol. Excess ethanol was removed by centrifugation at 15,000 g and aspiration, and the plasmid DNA pellet was air dried for 15-20 min and resuspended in 20 mL of nuclease-free distilled water. PCR primers and conditions. The oligonucleotide primers used in the study are shown in table 2; they were purchased from Metabion. Primers were designed using CLUSTALW multiple alignments (European Bioinformatics Institute; http:// www.ebi.ac.uk) of target gene homologs deposited in databases, and their specificity was determined in silico using BLAST software [29] . PCR reagents were purchased from Biotools. The reaction mixtures consisted of 1-5 mL of DNA preparation, 0.3 mmol/L each primer, 0.2 mmol/L dNTPs, 2.5 mL of 10ϫ amplification buffer, 1 U of Taq DNA polymerase, and doubledistilled water added to a final volume of 25 mL. PCR was performed in a PTC-200 thermocycler (MJ Research). The PCR mixture was subjected to initial denaturation for 5 min at 95ЊC, followed by 30 cycles of denaturation for 30 s at 95ЊC, primer annealing for 30 s at 56ЊC, and extension for 2 min at 72ЊC, with an additional extension step of 10 min at 72ЊC after the final cycle. The analytical sensitivity (detection limit) of each of the PCR assays was determined with 10-fold serial dilutions of total DNA from strains 103S and PAM 1220 (table 1) .
Statistical analysis. The proportions of the different types of plasmid were compared using contingency tables and 2-tailed x 2 tests or Fisher's exact test if the expected cell value was !5 observations. The threshold for statistical significance was . P ! .05
RESULTS AND DISCUSSION
Design of the traA PCR. Suitable targets for the development of a PCR assay for detecting plasmid-positive R. equi isolates should be present in all plasmid variants from this species. The only plasmid sequence available for R. equi, from the identical replicons p33701 and p103 [23] , contains several conjugal transfer genes. We chose a target from among these genes, traA, that encodes a putative relaxase/helicase conserved in other conjugative extrachromosomal elements from Rhodococcus species [24, 25] , on the assumption that all R. equi plasmids are related to p33701/p103 and share a similar conjugal transfer mechanism. From the p33701/p103 sequence (GenBank accession numbers AP001204 and AF116907), we designed the oligonucleotide primers TraA-F1 and TraA-R1, which amplify a 959-bp section of the traA gene. The TraA-F1 forward primer and the TraA-R1 reverse primer target nucleotide positions 1446-1465 and 2386-2405 of the traA gene, respectively. The primers were tested using total DNA from strain 103S and gave the expected amplicon with a detection limit of 10 pg. They were then pilot tested on a panel of 15 R. equi strains previously identified as vapA
, or vapAB Ϫ ( each) using n p 5 established PCR assays (i.e., primers IP1/IP2 for vapA [30] and H1/H2 for vapB [21] ; table 2). We previously determined, by alkaline extraction and agarose gel electrophoresis, that the 5 vapAB Ϫ strains contained plasmid material (see Materials and Methods). The 15 strains yielded 959-bp amplicons, and the sequencing of these confirmed that they all corresponded to the same traA gene fragment. Sequence identity to p33701/103 traA was 98%-100%, which indicated that this gene is highly conserved in R. equi plasmids of different types. We next tested the TraA-F1/R1 primer pair on 200 additional R. equi isolates from different sources. These isolates had previously been screened by the PCR tests for vapA and vapB described above. All strains giving a positive reaction for vapA or vapB ( ) were also positive by traA PCR, as detern p 124 mined by detection of the expected 959-bp amplicon. Of the 89 vapAB Ϫ strains, 40 (44.9%) tested positive with traA, which indicated that they could also contain a plasmid. Validation of the traA PCR as a "presence-of-plasmid" marker in R. equi. We assessed the performance of the traA PCR using plasmid extraction and visualization as the reference (see table 1 ); strains PAM 1126 (103S) and PAM 1272 (plasmid-cured ATCC 33701) were used as positive and negative controls, respectively. traA-vapA-vapB polymerase chain reaction results for each strain are indicated above the upper panel. Note in the lower panel that the traA signal in the new category of R. equi plasmid identified in the study, the "bovine" traA + /vapAB Ϫ type, is in an EcoRI fragment of a same or very similar size (≈23 kb) as that identified in vapA + ("horse-type") or vapB + ("pig-type") plasmids, which suggests that they share a common core genetic structure. M, II DIG-labeled (Roche Diagnostics) molecular-weight marker (sizes are indicated on the left in kilobases).
method. All of the traA + strains were found to contain extrachromosomal elements on examination of EcoRI digests of plasmid minipreparations, equivalent to a specificity of 100%. Such elements were readily detectable for most vapA + or vapB + strains. However, the visualization of plasmid material from traA + /vapAB Ϫ strains was more problematic, given that, in most cases, only a faint banding pattern was observed in agarose gels (see profiles of strains PAM 1681 and 1682 in figure 1, top) . We confirmed the presence of a plasmid in these strains by Southern-blot hybridization using a traA probe ( figure 1, bot Initial attempts to combine the TraA-F1/R1 primer pair with the previously described primers for vapA (IP1/IP2) [30] and vapB (H1/H2) [21] (see above) were unsuccessful because primers H1 and IP2 amplified both vapA and vapB when used together and because, in some cases, primer IP1 amplified vapB ). Note that (1) equine, porcine, and bovine P ! .001 isolates are associated with a specific plasmid category and (2) all plasmid categories are found in human isolates; the difference in traA
plasmid distribution between pigs and humans is statistically significant ( ). Plasmidless (traA Ϫ /vapAB Ϫ ) bacteria are more frequent P p .022 among isolates from nonpathological specimens (i.e., soil and healthy pig carriers; see table 1), but differences in the distribution of this category between groups are not statistically significant ( ). P p .0512 when used with primer H2 (data not shown). We designed a new set of primers that specifically amplified vapA and vapB targets when combined in multiplex format. The set includes 2 gene-specific forward primers and a common reverse primer: PvapAF (forward) targets nucleotide positions 221-239 of vapA (GenBank accession number D21236), PvapBF (forward) targets nucleotide positions 39-57 vapB (GenBank accession number D44469), and PABR (reverse) targets nucleotide positions 488-507 and 497-516 of vapA and vapB, respectively (table 2) . These primers were tested in simplex format against the collection of 215 R. equi isolates and gave results identical to those obtained with the IP1/IP2 [30] and H1/H2 [21] primers (table 1). The detection limit for the vapA (PvapAF/PABR) and vapB (PvapBF/PABR) PCRs was found to lie between 10 and 100 pg when total DNA from R. equi 103S (vapA) and PAM 1220 (vapB) was used. The amplicons generated with PvapAF/PABR and PvapBF/PABR have easily distinguishable sizes of 286 and 477 bp (figure 2).
Survey of R. equi field isolates with TRAVAP. We tested the PvapAF/PvapBF/PABR/TraA-F1/TraA-R1 primer mixture with the complete R. equi isolate collection and found results identical to those obtained in simplex format (table 1 ). An example of the amplicon profiles of the 4 categories of isolate distinguished on the basis of TRAVAP plasmid markers is shown in figure 2 ; a summary of the results obtained according to the origin of the isolates is shown in figure 3 .
Three clear patterns emerged from the analysis of the data. First, we confirmed previous observations [18, 21] that the vapA + and vapB + markers are never associated, which indicates that the 2 genes (or plasmid types, by extension) do not occur together in the same isolate. This mutual exclusivity suggests that vapA and vapB are allelic variants of a same locus that has divergently evolved in 2 different plasmid subpopulations. Second, although most (86.4%) equine isolates had plasmids, these were never associated with a vapB + marker, which suggests host (horse)-driven (counter)selection of the vapB-type plasmid. Third, and consistent with host-driven selection of plasmid types in R. equi, bovine isolates mostly (84.0%) had a plasmid, but none were associated with a vapA + marker. A previous study of bovine isolates reported no positive reactions for vapA or vapB, and this was interpreted as indicating the absence of virulence plasmids [9] . Our data clearly show that most bovine isolates do carry plasmids and that most of these (72%) are traA + /vapAB Ϫ , reflecting the existence of a specific plasmid type associated with the bovine host. Almost all equine and bovine isolates derived from bona fide clinical samples associated with clear pathology: purulent bronchopneumonia or mesenteric abscesses in horses and tuberculous-like granulomatous lymphadenitis in various locations in cattle (table 1) . Consistent with previous observations [11, 31] , pig isolates were predominantly associated (70.0%;
) with vapB-P p .0001 type plasmids ( figure 3 ). This finding, while indicating an association between the vapB + marker and pigs, is of unclear significance in terms of invasive infection, because most of these isolates were derived from submaxillary lymph nodes without macroscopic lesions (table 2) . Interestingly, no vapA + ("horsetype") or vapAB Ϫ ("bovine-type") plasmids were identified in pigs, pointing again to host-driven selection of plasmid types in R. equi. A greater percentage of pig strains (30.0% vs. 13.6% in horse isolates and vs. 16.0% in bovine isolates) lacked plasmids according to traA PCR results, which possibly reflects their isolation from apparently healthy carriers (in which the selective pressure to maintain a virulence plasmid would be expected to be weaker).
Isolates from soil were either vapA + (52.6%) or plasmidless (47.4%), consistent with these isolates being from horse-related environments and with the lack of importance of virulence plasmids for R. equi survival outside the host [6, 32] .
Human strains, all of which had been isolated from pathological specimens (table 1) , differed from the rest of the isolates in that all 4 TRAVAP plasmid categories were identified. This indicates that human hosts are susceptible to a variety of R. equi strains, with or without plasmids. The frequency of plasmids, as assessed from the traA + marker, was lower than that in pathological specimens from horses and cattle (76.8% vs. 86.4% and 84.0%, respectively), consistent with the primarily opportunistic nature of R. equi infection in humans and the dispensability of virulence plasmids in these conditions [6, 21] .
Conclusions. We have demonstrated the value of a new R. equi gene marker, traA, for rapid discrimination by PCR between plasmid-positive and plasmid-negative isolates. By integrating this marker with vapA and vapB markers, we have developed a useful PCR-based typing method. The application of this system to field isolates of R. equi suggested clear associations between specific plasmid types and animal hosts. 
